SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : bluebird bio Inc.
BLUE 4.9700.0%Jun 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (49)2/3/2014 2:13:18 PM
From: Biotech Jim  Read Replies (1) of 163
 
Concerning the one-and-done payment model discussed:

I posted that link since I feel that every gene therapy company and every investor in gene therapy companies should be asking "How much is a human life worth? Should the life worth value be pro-rated based on age of treatment? Where will the pricing of human drugs stop? Will there ever be a mandate on the maximum price of a human drug? Who will ultimately run the show, government? Paye(o)rs?"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext